Shijiazhuang Yiling Pharmaceutical Co., Ltd., a national key high-tech enterprise, was founded on June 16, 1992. The company takes “inheriting innovation and benefiting humanity” as its corporate purpose, “science and technology for a healthy tomorrow” as the enterprise development goal, takes healthy people as its mission, and benefits society. It always adheres to market-leading, technology-driven innovation and development strategies, drives the industrialization of traditional Chinese medicine with academic innovation in traditional Chinese medicine, and uses modern high-tech technology to develop traditional Chinese medicine, Western medicine and biopharmaceuticals. Establish a unique five-in-one operating model of “theory - clinical research - industry - teaching”. Mainly engaged in pharmaceutical production and sales. The main products include Tongxinluo capsules, Shensong Yangxin capsules, Lianhua Qingfeng capsules, Qiangxin capsules, etc. Corporate honors: In July 2020, Eling Pharmaceutical ranked 10th in the “2019 Top 100 Chinese Medicine Companies” (China Pharmaceutical Industry Top 100 Series List); in August 2020, Lianhua Qingfeng won the “2020 Healthy China* Brand Award” and “2020 Brand List* Most Clinical Value List” (2020 Sipuhui); in August 2020, Sansong Yangxin Capsule was ranked 3rd in the “2020 Health China* Brand List” (2020 Sipuhui). In September 2020, Eling Pharmaceutical ranked 3rd in the China Traditional Chinese Medicine R&D Strength Ranking (2020) Health Industry High Quality Development Conference and the 5th China Pharmaceutical R&D Innovation Summit “2020 China Traditional Chinese Medicine R&D Strength Ranking”), etc.
No Data